Problems in China pharmaceutical compulsory licensing system and their solutions

面对全球公共健康的严峻形式,《多哈宣言》赋予WHO成员国处理公共健康危机时,具有使用药品专利强制许可的权利。虽然我国已基本建立药品专利强制许可制度,但是在实际工作中存在实施效力较低、行政主管部门职责不清、制药企业对有关规定了解不足等诸多问题,需要改进、完善有关法律规定和相关制度,切实提高药物可及性。The Doha Declaration has entrusted to the members of WHO the right to use the compulsory licensing for drug patents in the face of global public health crises. Although the basic compulsory licensing system for drug patents has been established in China,the efficiency of its implementation is low,the responsibility of its executive departments is unclear,the related rules are not fully understood by pharmaceutical enterprises,it is thus necessary to improve and perfect the relevant legal provisions and systems in order to effectively improve the accessibility of drugs